Published Date: 08 Mar 2023
A computerized study examined the use of budesonide-formoterol as needed versus inhaled epinephrine for the management of asthma.
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on diagnosing parasomnias!
Late-breaking data from the 2026 ACTRIMS Forum showed that bazedoxifene acetate failed to improve remyelination outcomes in midlife women with relapsing MS, despite a favorable safety profile.
A nurse practitioner at the Rocky Mountain MS Clinic discussed emerging therapeutics, evolving management strategies, and unmet needs in multiple sclerosis, specifically in women’s health.
The FDA has granted priority review to Takeda’s new drug application for oveporexton, an orexin receptor 2-selective agonist, for narcolepsy type 1, with a PDUFA date in the third quarter of 2026.
Paul Nghiem highlights several key takeaways from his talk on cutaneous oncology, touching on various advances in skin cancer management.
VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial
REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis
1.
A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.
2.
High numbers of rural patients cross state lines for cancer care
3.
Updates from the 2022 WHO classification of kidney epithelial tumors
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
High levels of traumatic stress found in caregivers of adult cancer patients
1.
IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System
2.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
3.
Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer
4.
Sound Waves and Self-Destruction: A Promising Nanotech Weapon in the Fight Against Cancer
5.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
2.
Updates on the First Line Management of ALK+ NSCLC
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation